Top Cancer Stocks in Australia
Browse the largest Australia companies in the world ranked by their Market Capitalization. Global Cancer Companies in Australia market cap is $0.
19 Dec 2024, 02:54 UTC
Companies: 0
🇦🇺1 |  | $15.85 | 1.51% | 5.13B | 146.53% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺2 |  | $0.18 | 9.43% | 1.19B | 5700.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺3 |  | $0.22 | -5.48% | 196.01M | -1.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺4 |  | $0.02 | -5.13% | 148.82M | -66.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺5 |  | $0.11 | 9.09% | 81.53M | 50.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺6 |  | $0.11 | -5.56% | 34.74M | 47.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺7 |  | $0.35 | 4.76% | 32.22M | -18.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺8 |  | $0.05 | 10.61% | 30.47M | 265.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺9 |  | $0.06 | -5.00% | 17.67M | 28.38% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺10 |  | $0.00 | 0.00% | 8.80M | -22.22% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇦🇺11 |  | $0.00 | -25.00% | 3.93M | -62.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
